Nothing Special   »   [go: up one dir, main page]

Schneck et al., 2000 - Google Patents

Monitoring antigen‐specific T cells using MHC‐Ig dimers

Schneck et al., 2000

Document ID
8662086041968680597
Author
Schneck J
Slansky J
O'Herrin S
Greten T
Publication year
Publication venue
Current protocols in immunology

External Links

Snippet

The lack of high affinity reagents has made distinguishing T cells on the basis of antigen specificity difficult to accomplish. This unit provides protocols that utilize innovations in molecular design to permit construction of soluble multivalent MHC complexes (MHC‐Ig …
Continue reading at currentprotocols.onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Similar Documents

Publication Publication Date Title
Schneck et al. Monitoring antigen‐specific T cells using MHC‐Ig dimers
Goel et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Loyal et al. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Workman et al. The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells
Poorebrahim et al. Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects
CN110291402B (en) Method for identifying peptide epitopes, molecules binding such epitopes and related uses
Abolhassani et al. Combined immunodeficiency and Epstein-Barr virus–induced B cell malignancy in humans with inherited CD70 deficiency
Boles et al. A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC
Mehlhop-Williams et al. Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation
Quigley et al. CXCR5+ CCR7–CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles
Foster et al. Detection of intracellular cytokines by flow cytometry
Jelicic et al. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression
Alam et al. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
McCausland et al. SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase
Shuford et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
Arnon et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30
Sester et al. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus
Hendriks et al. CD27 is required for generation and long-term maintenance of T cell immunity
Holtappels et al. Cytomegalovirus encodes a positive regulator of antigen presentation
Hartmann et al. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding
Forrest et al. Structure-function analysis of reovirus binding to junctional adhesion molecule 1: implications for the mechanism of reovirus attachment
Fuse et al. CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68
Holtappels et al. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65)
Cheng et al. Discovery of a transferrin receptor 1-binding aptamer and its application in cancer cell depletion for adoptive T-cell therapy manufacturing
JP2008148707A (en) Dendritic cell-specific antibody